Bill Louv, PhD
Bill was named Chief Executive Officer of the CEO Roundtable on Cancer effective March 2022 after serving as Interim CEO since January 2022. He joined Project Data Sphere in April 2018, bringing with him broad leadership experience in statistics, epidemiology, and information technology. Throughout his career he has held key leadership positions in the pharmaceutical industry, most recently as a member of GlaxoSmithKline’s Corporate Executive Management team from 2007 until his retirement in 2016.
He joined the pharmaceutical industry in 1986 as head of biostatistics at Merrell Dow and advanced to the position of VP of biostatistics, epidemiology and clinical data management at GlaxoWellcome in 1998. He made a significant career change in 1999 when he became Vice President of IT for GlaxoSmithKline’s R&D organization. Bill was named Chief Information Officer for GSK in 2007. In 2011, Bill was promoted to Senior Vice President of Core Business Services which included IT, Procurement, Accounting, and Real Estate.
Bill has consulted with many organizations on health care analytics and opportunities to leverage big data. He is a Non-Executive Director of River Logic Inc., a leader in Prescriptive Analytics and Integrated Business Planning, and he is Deputy Chairman of ClinPal, a cloud-based clinical trial platform.
Early in his career Bill was a member of technical staff at Bell Laboratories, where he developed forecasting algorithms for signaling networks. Subsequently he was Associate Professor of Biostatistics at the University of Alabama at Birmingham. Bill published more than 25 academic papers while at these research organizations. He earned a bachelor’s degree from the College of William and Mary and a doctorate from the University of Florida.